Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Cellebrite DI Ltd (NASDAQ: CLBT) closed at $16.84 in the last session, up 1.08% from day before closing price of $16.66. In other words, the price has increased by $1.08 from its previous closing price. On the day, 1.29 million shares were traded.
Ratios:
We take a closer look at CLBT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.18. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’25 when DAVID GEE bought 12,150 shares for $16.71 per share.
DAVID GEE bought 10,555 shares of CLBT for $179,963 on May 21 ’25. On May 20 ’25, another insider, AYALA BERLER SHAPIRA, who serves as the Officer of the company, bought 5,628 shares for $17.02 each.
Stock Price History:
Over the past 52 weeks, CLBT has reached a high of $26.30, while it has fallen to a 52-week low of $10.29. The 50-Day Moving Average of the stock is -9.11%, while the 200-Day Moving Average is calculated to be -12.55%.
Shares Statistics:
A total of 239.47M shares are outstanding, with a floating share count of 108.96M. Insiders hold about 54.50% of the company’s shares, while institutions hold 37.03% stake in the company.
